328 related articles for article (PubMed ID: 12939232)
1. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
[TBL] [Abstract][Full Text] [Related]
2. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR.
Pomposiello SI; Carroll MA; Falck JR; McGiff JC
Hypertension; 2001 Mar; 37(3):887-93. PubMed ID: 11244013
[TBL] [Abstract][Full Text] [Related]
3. The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids.
Chen YJ; Jiang H; Quilley J
J Pharmacol Exp Ther; 2003 Mar; 304(3):1292-8. PubMed ID: 12604709
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.
Fulton D; Mcgiff JC; Quilley J
J Pharmacol Exp Ther; 1998 Nov; 287(2):497-503. PubMed ID: 9808672
[TBL] [Abstract][Full Text] [Related]
5. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.
Yu Z; Huse LM; Adler P; Graham L; Ma J; Zeldin DC; Kroetz DL
Mol Pharmacol; 2000 May; 57(5):1011-20. PubMed ID: 10779386
[TBL] [Abstract][Full Text] [Related]
6. Vasodilatory effect of 14,15-epoxyeicosatrienoic acid on mesenteric arteries in hypertensive and aged rats.
Yang C; Yang J; Xu X; Yan S; Pan S; Pan X; Zhang C; Leung GP
Prostaglandins Other Lipid Mediat; 2014 Aug; 112():1-8. PubMed ID: 24880050
[TBL] [Abstract][Full Text] [Related]
7. Neuronal NO mediates cerebral vasodilator responses to K+ in hypertensive rats.
Chrissobolis S; Ziogas J; Anderson CR; Chu Y; Faraci FM; Sobey CG
Hypertension; 2002 Apr; 39(4):880-5. PubMed ID: 11967243
[TBL] [Abstract][Full Text] [Related]
8. KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.
Simonet S; Isabelle M; Bousquenaud M; Clavreul N; Félétou M; Vayssettes-Courchay C; Verbeuren TJ
Br J Pharmacol; 2012 Oct; 167(4):854-67. PubMed ID: 22646737
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats.
Omata K; Abraham NG; Escalante B; Schwartzman ML
Am J Physiol; 1992 Jan; 262(1 Pt 2):F8-16. PubMed ID: 1733300
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
11. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
12. Impaired nitric oxide-independent dilation of renal afferent arterioles in spontaneously hypertensive rats.
Hayashi K; Matsuda H; Nagahama T; Fujiwara K; Ozawa Y; Kubota E; Honda M; Tokuyama H; Saruta T
Hypertens Res; 1999 Mar; 22(1):31-7. PubMed ID: 10221348
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels.
Udosen IT; Jiang H; Hercule HC; Oyekan AO
Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2054-63. PubMed ID: 12881223
[TBL] [Abstract][Full Text] [Related]
15. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat.
Ogungbade GO; Akinsanmi LA; Jiang H; Oyekan AO
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F955-64. PubMed ID: 12865253
[TBL] [Abstract][Full Text] [Related]
16. 11,12-Epoxyeicosatrienoic acid induces vasodilator response in the rat perfused mesenteric vasculature.
Bihzad SM; Yousif MH
Auton Autacoid Pharmacol; 2017 Jan; 37(1):3-12. PubMed ID: 28332266
[TBL] [Abstract][Full Text] [Related]
17. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway.
Carroll MA; Doumad AB; Li J; Cheng MK; Falck JR; McGiff JC
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F155-61. PubMed ID: 16478979
[TBL] [Abstract][Full Text] [Related]
18. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins.
Carroll MA; Balazy M; Margiotta P; Falck JR; McGiff JC
J Biol Chem; 1993 Jun; 268(17):12260-6. PubMed ID: 8509363
[TBL] [Abstract][Full Text] [Related]
19. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells.
Fang X; Weintraub NL; Stoll LL; Spector AA
Hypertension; 1999 Dec; 34(6):1242-6. PubMed ID: 10601125
[TBL] [Abstract][Full Text] [Related]
20. Role of cytochrome P450 metabolites of arachidonic acid in regulation of corporal smooth muscle tone in diabetic and older rats.
Yousif MH; Benter IF
Vascul Pharmacol; 2007; 47(5-6):281-7. PubMed ID: 17855173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
